Aadi Bioscience
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $7,239 | $7,212 | $6,179 | $5,353 |
Gross Profit | 6,449 | 6,408 | 5,401 | 4,701 |
EBITDA | -18,902 | -12,461 | -14,475 | -18,181 |
EBIT | -18,949 | -12,508 | -14,524 | -18,231 |
Net Income | -18,273 | -12,546 | -14,583 | -18,289 |
Net Change In Cash | 7,239 | 7,212 | 6,179 | 5,353 |
Free Cash Flow | -15,239 | -20,484 | -9,698 | -20,392 |
Cash | 28,670 | 30,537 | 41,139 | 53,780 |
Basic Shares | 27,086 | 24,741 | 27,010 | 26,980 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $25,983 | $24,354 | $15,216 | $1,000 |
Gross Profit | 22,959 | 21,545 | 13,881 | 724 |
EBITDA | -64,625 | -65,365 | -60,124 | -109,147 |
EBIT | -64,819 | -65,534 | -60,283 | -109,423 |
Net Income | -63,691 | -65,765 | -57,010 | -110,090 |
Net Change In Cash | 25,983 | 24,354 | 15,216 | 1,000 |
Cost of Revenue | 144,534 | |||
Free Cash Flow | -61,204 | -63,635 | -50,084 | -22,469 |
Cash | 28,670 | 62,888 | 39,019 | 148,989 |
Basic Shares | 27,029 | 26,917 | 22,511 | 8,923 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.67 |
2024-09-30 | -$0.46 |
2024-06-30 | -$0.54 |
2024-03-31 | -$0.68 |
